Epinephrine Administration in Schools

Senate and House sponsorship lists were reordered to appear in their proper legislative sequence.

Bill summary and committee information were relocated to the top of the document for better organization.

Page headers and formatting were updated to reflect the Rerevised version status.

Added a note about legislative status and signatures to the bill header

Corrected spacing and indentation in the bill title and sponsor list

Fixed typo in statute title by adding 'management' back to the full title

Corrected cross-reference from paragraph (a) to paragraph (c) in subsection (5.5)

Fixed cross-reference from paragraphs (c) and (f) to paragraphs (e) and (f) in subsection (5.5)

Corrected typo 'auto-injeetors' to 'auto-injectors' in subsection (5.5)(d)

Removed deleted text about detailed training program standards from subsection (8)(g)

Added definition of 'designated school personnel' to clarify who can administer epinephrine beyond just school nurses.

Added new reporting requirements for schools to submit incident reports and training status to the department of education.

Added detailed training standards that must be completed by school nurses and designated personnel before administering epinephrine.

Modified requirements for nonpublic schools to implement education plans based on state board rules to qualify for liability protections.

Added liability protections for schools and employees who act in good faith when administering emergency-use epinephrine.

Added authority for schools to enter arrangements with manufacturers to obtain epinephrine at fair-market or reduced prices or for free.

Added seven new Senate sponsors: Amabile, Ball, Bright, Carson, Catlin, Coleman, Cutter, Daugherty, Exum, Frizell, Gonzales J., Jodeh, Kipp, Michaelson Jenet, Roberts, Snyder, Wallace.

Updated header text from 'ENGROSSED' to 'REENGROSSED' and added a note indicating the bill summary will apply to the reengrossed version after third reading.

Removed page 3 content containing subsections 5.5(e), 5.5(f), and 6 regarding epinephrine auto-injector liability protections, likely due to formatting or amendment incorporation.

Added Appropriations committee to Senate committee oversight list

Updated page numbering from 'SB25-278' to '278' in footer

Added '2nd Reading Unamended' status stamp dated April 22, 2025